NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 137 filers reported holding NEOGENOMICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69,988 | +88.4% | 4,020 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $37,145 | -92.6% | 4,020 | -61.4% | 0.00% | -93.8% |
| Q3 2021 | $502,000 | +3.9% | 10,408 | -2.6% | 0.02% | +6.7% |
| Q2 2021 | $483,000 | -5.3% | 10,687 | +1.0% | 0.02% | -21.1% |
| Q1 2021 | $510,000 | -61.4% | 10,576 | -56.9% | 0.02% | -64.2% |
| Q4 2020 | $1,320,000 | +176.7% | 24,511 | +89.4% | 0.05% | +140.9% |
| Q3 2020 | $477,000 | +19.0% | 12,938 | 0.0% | 0.02% | 0.0% |
| Q2 2020 | $401,000 | -10.1% | 12,938 | -19.8% | 0.02% | -24.1% |
| Q1 2020 | $446,000 | -25.9% | 16,140 | -21.5% | 0.03% | -9.4% |
| Q4 2019 | $602,000 | +9933.3% | 20,566 | +7351.4% | 0.03% | – |
| Q3 2019 | $6,000 | 0.0% | 276 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | +500.0% | 276 | +160.4% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 106 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |